Φορτώνει......
Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
BACKGROUND: Majority of patients of hepatocellular carcinoma (HCC) in India present in advanced stages, when curative treatment options are limited. We undertook this study to assess the cost-effectiveness of treating advanced HCC patients with sorafenib compared with best supportive care (BSC). MET...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Exp Hepatol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728525/ https://ncbi.nlm.nih.gov/pubmed/31516263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.10.003 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|